173.39
173.39 (0%)
As of Feb 14, 2025
Natera, Inc. [NTRA]
Source:
Company Overview
Natera, Inc. is a diagnostics company with proprietary molecular and bioinformatics technology that we are applying to change the management of disease worldwide.
| Country | United States |
| Headquarters | austin, texas |
| Phone Number | (650) 980-9190 |
| Industry | services |
| CEO | Steve Chapman |
| Website | www.natera.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $1,696.9 |
| Operating Profit | $-222.3 |
| Net Income | $-190.4 |
| Net Cash | $303.5 |
Profit Ratios
| Gross Margin | $1,696.9 |
| Operating Margin | -13.1 |
| Profit as % of Revenues | -891.1% |
| Profit as % of Assets | -12.3% |
| Profit as % of Stockholder Equity | -15.9% |
Management Effectiveness
| Return on Equity | -15.9% |
| Return on Assets | -11.5% |
| Turnover Ratio | 109.4% |
| EBITA | $-222.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,660.7 |
| Total Liabilities | $465.3 |
| Operating Cash Flow | $135.7 |
| Investing Cash Flow | $137.6 |
| Financing Cash Flow | $30.2 |
